Facebook Twitter Google+ LinkedIn Youtube Follow us on:
06/10/2014 :
Cellectis enters into an agreement with CELLforCURE for the cGMP manufacturing of allogeneic CART cells
Read all
05/27/2014 :
LFB in 2013: moderate growth and an increase in profitability
Read all
05/15/2014 :
LFB announces First patient has begun treatment with Factor VIIa (Recombinant) in Phase III Clinical Trial in Hemophilia A and B with inhibitors
Read all
LFB Group Web Sites